Skip to main content

Advertisement

ADVERTISEMENT

Podcasts

IBD Drive time logo
Podcast
10/07/2022
Dr Freddy Caldera from the University of Wisconsin talks to IBD Drive Time host Dr Raymond Cross from the University of Maryland on advising patients with IBD about vaccines for COVID-19, monkeypox, and pneumonia.
Dr Freddy Caldera from the University of Wisconsin talks to IBD Drive Time host Dr Raymond Cross from the University of Maryland on advising patients with IBD about vaccines for COVID-19, monkeypox, and pneumonia.
Dr Freddy Caldera from the...
10/07/2022
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
08/02/2022
Dr Millie Long discusses a recent study into depression and anxiety among patients with IBD conducted by her IBD Drive Time cohost, Dr Raymond Cross, and Laurie Keefer, PhD, a GI health psychologist.
Dr Millie Long discusses a recent study into depression and anxiety among patients with IBD conducted by her IBD Drive Time cohost, Dr Raymond Cross, and Laurie Keefer, PhD, a GI health psychologist.
Dr Millie Long discusses a...
08/02/2022
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
07/31/2022
In this episode of IBD Drive Time, host Raymond Cross, MD, from the University of Maryland School of Medicine, discusses treatment options, positioning of therapies, and surgical approaches to perianal Crohn disease with Dr David Schwartz...
In this episode of IBD Drive Time, host Raymond Cross, MD, from the University of Maryland School of Medicine, discusses treatment options, positioning of therapies, and surgical approaches to perianal Crohn disease with Dr David Schwartz...
In this episode of IBD Drive...
07/31/2022
Advances in Inflammatory Bowel Disease Network

Advertisement

IBD Drive time logo
Podcast
07/12/2022
In this episode of IBD Drive Time, hosts Raymond Cross, MD, and Millie Long, MD, talk to Dr Sara Horst of Vanderbilt University about the newly approved IL-23 inhibitor, risankizumab, and its benefit in treating inflammatory bowel disease.
In this episode of IBD Drive Time, hosts Raymond Cross, MD, and Millie Long, MD, talk to Dr Sara Horst of Vanderbilt University about the newly approved IL-23 inhibitor, risankizumab, and its benefit in treating inflammatory bowel disease.
In this episode of IBD Drive...
07/12/2022
Advances in Inflammatory Bowel Disease Network
IBD Drive Time podcast logo
Podcasts
06/22/2022
In this episode of IBD Drive Time, your hosts Drs Ray Cross and Millie Long discuss the best abstracts from Digestive Disease Week 2022 with Dr Dave Hudesman.
In this episode of IBD Drive Time, your hosts Drs Ray Cross and Millie Long discuss the best abstracts from Digestive Disease Week 2022 with Dr Dave Hudesman.
In this episode of IBD Drive...
06/22/2022
Advances in Inflammatory Bowel Disease Network
logo
Podcast
06/01/2022
In this episode of IBD Drive Time, guest Meena Bewtra, MD, from the University of Pennsylvania, joins hosts Raymond Cross, MD, from the University of Maryland and Millie Long, MD, from the University of North Carolina, to discuss top...
In this episode of IBD Drive Time, guest Meena Bewtra, MD, from the University of Pennsylvania, joins hosts Raymond Cross, MD, from the University of Maryland and Millie Long, MD, from the University of North Carolina, to discuss top...
In this episode of IBD Drive...
06/01/2022
Advances in Inflammatory Bowel Disease Network

Advertisement

IBD Drive Time podcast logo
Podcasts
05/16/2022
In this episode of IBD Drive Time, Parambir Dulai, MD, joins our hosts to discuss the best of ECCO 2022 in diagnostics, natural history, and epidemiology.
In this episode of IBD Drive Time, Parambir Dulai, MD, joins our hosts to discuss the best of ECCO 2022 in diagnostics, natural history, and epidemiology.
In this episode of IBD Drive...
05/16/2022
Advances in Inflammatory Bowel Disease Network
Benjamin Cohen, MD
Podcasts
05/09/2022
In this podcast, Dr Cohen discusses his recent research into whether the use of tumor necrosis factor (TNF) inhibitors is associated with a higher rate of postoperative infection among patients with IBD.
In this podcast, Dr Cohen discusses his recent research into whether the use of tumor necrosis factor (TNF) inhibitors is associated with a higher rate of postoperative infection among patients with IBD.
In this podcast, Dr Cohen...
05/09/2022
Advances in Inflammatory Bowel Disease Network
IBD Drive Time podcast logo
Podcasts
05/04/2022
On the latest episode of IBD Drive Time, our hosts Drs Ray Cross and Millie Long discuss extraintestinal manifestations with Dr Rieder.
On the latest episode of IBD Drive Time, our hosts Drs Ray Cross and Millie Long discuss extraintestinal manifestations with Dr Rieder.
On the latest episode of IBD...
05/04/2022
Advances in Inflammatory Bowel Disease Network

Advertisement

Phillip Fleshner
Podcast
04/30/2022
In this podcast, Dr Phillip Fleshner, director of colorectal surgery at Cedars-Sinai Medical Center in Los Angeles, discusses the complexities of medical and surgical treatment of perianal and fistulizing Crohn disease, which he spoke about...
In this podcast, Dr Phillip Fleshner, director of colorectal surgery at Cedars-Sinai Medical Center in Los Angeles, discusses the complexities of medical and surgical treatment of perianal and fistulizing Crohn disease, which he spoke about...
In this podcast, Dr Phillip...
04/30/2022
Advances in Inflammatory Bowel Disease Network

Advertisement